Hinge Health (NYSE:HNGE) Major Shareholder Insight Holdings Group, Llc Sells 142,311 Shares

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $71.67, for a total transaction of $10,199,429.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total value of $27,813,744.55.
• On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total value of $7,897,010.17.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total value of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total value of $4,614,279.16.

Hinge Health Stock Performance

Shares of Hinge Health stock opened at $74.86 on Friday. Hinge Health Inc. has a 52 week low of $30.08 and a 52 week high of $75.17. The stock has a 50 day moving average price of $56.17 and a two-hundred day moving average price of $47.33. The stock has a market capitalization of $5.79 billion and a PE ratio of -6.07.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. The company had revenue of $182.31 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.Hinge Health’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.30 earnings per share. Research analysts forecast that Hinge Health Inc. will post 1.33 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently commented on HNGE. Royal Bank Of Canada boosted their target price on shares of Hinge Health from $65.00 to $75.00 and gave the stock an “outperform” rating in a research report on Thursday, June 11th. Wall Street Zen cut shares of Hinge Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 6th. Raymond James Financial boosted their price objective on Hinge Health from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Stifel Nicolaus set a $79.00 price objective on Hinge Health in a research note on Wednesday, June 10th. Finally, Barclays increased their price objective on Hinge Health from $62.00 to $70.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Hinge Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.80.

Institutional Investors Weigh In On Hinge Health

Institutional investors have recently added to or reduced their stakes in the company. Marshall Wace LLP purchased a new stake in Hinge Health in the 2nd quarter valued at about $367,000. Sei Investments Co. purchased a new position in shares of Hinge Health in the 2nd quarter worth approximately $869,000. Squarepoint Ops LLC bought a new position in shares of Hinge Health in the second quarter valued at approximately $19,706,000. Raymond James Financial Inc. purchased a new stake in shares of Hinge Health during the second quarter valued at approximately $3,258,000. Finally, Sandia Investment Management LP purchased a new stake in shares of Hinge Health during the second quarter valued at approximately $657,000.

Trending Headlines about Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Hinge Health raised its Q2 2026 revenue guidance to $200 million-$202 million, above the Street’s $195 million estimate, and lifted full-year 2026 revenue guidance to $818 million-$824 million versus consensus of $801.6 million, signaling better-than-expected growth momentum.
• Positive Sentiment: Recent operating results remain strong, with the company’s last reported quarter showing 47.2% revenue growth and earnings that beat analyst expectations, helping support bullish sentiment around the stock.
• Neutral Sentiment: Wall Street remains broadly constructive on Hinge Health, with recent analyst price targets ranging from the high-$70s to $90 and a consensus rating of Moderate Buy, suggesting investors still see upside potential.
• Negative Sentiment: Insight Holdings Group, a major shareholder, sold multiple large blocks of HNGE shares in recent days, including transactions on June 22, June 23, and June 24. Although the sales were made under a pre-arranged Rule 10b5-1 plan, the volume of selling may pressure sentiment. SEC filing
• Negative Sentiment: President James Pursley also sold 33,000 shares, adding to the cluster of insider sales and raising questions about valuation after the stock’s recent run-up. SEC filing

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.